Who is the sponsor?
Genentech (Roche), Inc. and California Retina Consultants
Who are the patients?
Individuals with diabetic macular edema unresponsive to previous treatment.
How long is the trial?
What is the enrollment goal for the sponsor?
What is this study investigating?
To assess the role of ranibizumab therapy in individuals with diabetic macular edema unresponsive to previous medical treatment.